Physician

Daniel Alfaro, M.D.

According to 2025 Medicare claims, Daniel Alfaro, M.D. (NPI: 1982719290) practices ophthalmology in the Charleston-North Charleston, SC market, with the plurality of this provider's patient population coming from Berkeley, SC. This provider's primary affiliated billing organization is CHARLESTON NEUROSCIENCES INSTITUTE (NPI: 1225094600; TIN: 202359956) and primary practice location at 29456-4118.

Alfaro's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,427 traditional Medicare patients, billed 16,015 HCPCS/CPT codes, and received $2,741,034 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 368 prescription claims across 198 beneficiaries totaling $25,848 in drug costs, led by Tobradex St (Tobramycin/Dexamethasone). Open Payments data shows 269 records totaling $885,227. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,557	13,470	$955,809
2016	1,679	13,992	$951,075
2017	1,703	18,563	$2,936,238
2018	1,705	21,487	$4,089,910
2019	1,531	19,857	$3,805,336
2020	1,411	21,669	$3,955,230
2021	1,466	21,663	$3,751,392
2022	1,542	19,503	$3,489,342
2023	1,561	17,287	$3,737,282
2024	1,427	16,015	$2,741,034

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	188	424	$57,305
2016	189	408	$59,175
2017	166	394	$51,701
2018	154	353	$51,500
2019	182	397	$55,375
2020	138	398	$55,499
2021	187	456	$73,356
2022	167	412	$73,979
2023	209	385	$50,366
2024	198	368	$25,848

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
67028	Injection of drug into eye	364	1,483	$97
92014	Established patient complete exam of visual system	565	591	$83
92012	Established patient problem focused exam of visual system	527	649	$66
92134	Imaging of retina	1,033	2,154	$29
92250	Photography of the retina	530	620	$24

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tobradex St	Tobramycin/Dexamethasone	16	426	$3,689
Combigan	Brimonidine Tartrate/Timolol	12	408	$3,298
Prednisolone Acetate	Prednisolone Acetate	113	2,950	$2,944
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	21	867	$2,062
Bromfenac Sodium	Bromfenac Sodium	13	297	$1,757

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	28	$879	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	241	$884,348	Bayer Healthcare Pharmaceuticals Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Daniel Alfaro, M.D.?

Tedicare shows public-source Medicare data for Daniel Alfaro, M.D. (NPI 1982719290), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel Alfaro, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Daniel Alfaro, M.D.?

Daniel Alfaro, M.D. is linked to CHARLESTON NEUROSCIENCES INSTITUTE (billing NPI 1225094600) in the available physician profile data.

Does Daniel Alfaro, M.D. have Open Payments data?

Daniel Alfaro, M.D. has 269 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.